Home > Healthcare > Drug Device Combination > Therapeutic Systems > Amniotic Membrane Market

Amniotic Membrane Market Size

Report ID: GMI8336
Published Date: Oct 2024
Report Format: PDF

Download Free Sample

Amniotic Membrane Market Size

The global amniotic membrane market size was valued at around USD 1.7 billion in 2023 and is estimated to grow at a 7.9% CAGR from 2024 to 2032. The amniotic membrane is a thin, flexible tissue that lines the amniotic sac during pregnancy. It surrounds and protects the developing fetus while providing essential nutrients and growth factors. After childbirth, it can be used in medical treatments and surgeries for its regenerative properties and ability to promote healing.

To get key market trends

Download Free Sample

Growing demand for regenerative medicine is anticipated to drive market growth. Regenerative medicine aims to restore or replace damaged tissues and organs using techniques such as stem cell therapy, tissue engineering, and biomaterials. Amniotic membranes are increasingly recognized for their potential in these applications due to their unique properties. A 2023 study published by the National Library of Medicine highlighted the presence of key bioactive molecules in the amniotic membrane, underscoring their regenerative properties.

Amniotic Membrane Market Report Attributes
Report Attribute	Details
Base Year:	2023
Amniotic Membrane Market Size in 2023:	USD 1.7 Billion
Forecast Period:	2024 - 2032
Forecast Period 2024 - 2032 CAGR:	7.9%
2032 Value Projection:	USD 3.2 Billion
Historical Data for:	2018 - 2023
No. of Pages:	130
Tables, Charts & Figures:	219
Segments covered:	Product, Application, End-use, and Region
Growth Drivers:	Growing demand for regenerative medicine Rising incidence of chronic wounds Advancements in biotechnology and tissue engineering Increasing awareness and acceptance of amniotic membrane products
Pitfalls & Challenges:	Limited shelf life of amniotic membrane products Stringent regulatory polices

Learn more about the key segments shaping this market

Download Free Sample

Additionally, the rising incidence of chronic wounds, advancements in biotechnology and tissue engineering, and increasing awareness and acceptance of amniotic membrane products also support revenue growth in the market. Educational initiatives, including medical conferences and training programs, are promoting an understanding among clinicians. Simultaneously, patient awareness and demand for advanced therapies have increased with greater access to medical information and advocacy efforts.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The industry was valued at approximately USD 1.7 billion in 2023 and is estimated to grow at a 7.9% CAGR from 2024 to 2032, driven by its regenerative properties and applications in medical treatments and surgeries.

The cryopreserved segment is forecasted to reach USD 1.7 billion by 2032 due to its extensive use in various medical disciplines, such as ophthalmology, where it treats corneal defects, promotes faster healing, and reduces inflammation and scarring.

The U.S. market is projected to reach USD 1.1 billion by 2032, driven by well-established healthcare facilities, leading industry players, a focus on regenerative medicine, and the rapid adoption of advanced technologies.

Prominent participants include Amnio Technology, LLC, Applied Biologics LLC, BioTissue Holdings Inc., Celularity Inc., Corza Health, Inc., Integra LifeSciences Holdings Corporation, MiMedx Group, Inc., Organogenesis Holdings Inc., Skye Biologics, Inc., and Smith & Nephew plc.